Forwardly, Inc. Adds Dr. Michael J. Soffer MD to Medical Advisory Board

Boulder City, Nevada--(Newsfile Corp. - July 24, 2020) - George Sharp, President and CEO of Forwardly, Inc. (OTC Pink: FORW), announced today that Dr. Michael J. Soffer has been added to the Medical Advisory Board of Forwardly and its wholly owned subsidiary, Breathe Medical Devices, Inc.

A graduate of the University of Southern California School of Medicine, where he was the President of the Alpha Omega Alpha Honor Medical Society, Dr. Michael J. Soffer recently retired from a 41 year practice as an Internal Medicine and Pulmonary specialist.

A fellow at the UCLA School of Medicine, Dr. Soffer has served as Medical Director of Hancock Park Convalescent Hospital in Los Angeles, Medical Director of the Subacute Care Unit at the Fountain View Convalescent Hospital, and Chairman of the Midway Hospital Clinical Workstation Hospital Computerization Program. He has also taught at Cedars-Sinai Medical Center and at the UCLA Center for the Health Sciences. Dr. Soffer has served as a Diplomat for the National Board of Medical Examiners, the American Board of Pulmonary Diseases, and the American Board of Internal Medicine and has had two of his research efforts patented. His scientific memberships include the American College of Physicians-American Society of Internal Medicine, the American College of Chest Physicians, and the American College of Physicians.

The function of the Medical Advisory Board is to provide insight, scientific direction, and expertise to the Company. The members of this group are recognized experts in pulmonary medicine from leading academic and medical institutions.

Mr. Sharp commented, "As a new entrant into the business of development and sales of medical devices, Forwardly/Breathe Medical Devices provide Medical Advisory Board members with a stellar opportunity to shape the company's mission. We rely on this group to provide medical expertise and represent us when addressing technical issues with Ligand Global Innovation, Inc. and other manufacturers with whom we may choose to undertake a relationship, as well as sub distributors or end users of our product line. Forwardly is fortunate to have someone with the surpassing qualifications of Dr. Soffer interested in our quest to bring affordable ventilators to the medical community."

Together with Ligand Innovation Global, Inc., Forwardly, through its wholly owned subsidiary, Breathe Medical Devices, is working to bringing a new line of low-cost ventilators to the medical community. The Life Air G1 is designed to require no intubation or sedation and will be transportable to the patient. This makes the Life Air G1 not only ideal for use in hospitals, convalescent homes, care centers and even home use, but in locations where other life-saving equipment such as defibrillators are found, including, ambulances, commercial aircraft, sporting venues and cruise ships. Breathe Medical Devices owns the exclusive USA distribution rights for Life Air G1 and is working to acquire equity in Ligand Global Innovation in the near term.

More information about Life Air G! can be found at the company's website www.BreatheMedicalDevices.com

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.

CONTACT:

Forwardly, Inc.
1022 Nevada Highway
Boulder City, NV 89005
702-840-4433

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/60451